Evidence map›Paper›PMID 31731792›Full record

ArticleNutrients2019

Polydatin Inhibits NLRP3 Inflammasome in Dry Eye Disease by Attenuating Oxidative Stress and Inhibiting the NF-κB Pathway.

Bongkyun Park, Kyuhyung Jo, Tae Gu Lee, Soo-Wang Hyun, Jin Sook Kim, Chan-Sik Kim

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Oxidative Stress in Dry Eye Disease: A Bibliometric Analysis.Clinical ophthalmology (Auckland, N.Z.) · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease.International journal of molecular sciences · 2023
    Review
  20. International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bongkyun ParkClinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.
Kyuhyung JoHerbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.
Tae Gu LeeClinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.ORCID 0000-0001-8292-241X
Soo-Wang HyunHerbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.
Jin Sook KimHerbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.
Chan-Sik KimClinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.ORCID 0000-0001-7610-9887
Korea Institute of Oriental Medicine · KR

Funding

Korea Institute of Oriental Medicine KSN1812080Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries 317033-03
6 · The paper itself

Abstract

Polydatin (also named pieceid, (E)-piceid, (E)-polydatin, trans-polydatin, or 3,5,4'-trihydroxystilbene-3-b-D-glucoside) is a monocrystalline compound isolated from the root and rhizome of

Indexed as

AnimalsDisease Models, AnimalDry Eye SyndromesFallopia japonicaGlucosidesInflammasomesNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinOxidative StressPlant RootsRatsSignal TransductionStilbenesGlucosidesInflammasomesNF-kappa BNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratpolydatinStilbenesconjunctival celldry eye diseaseinflammationNLRP3 inflammasomepolydatinreactive oxygen species

Identifiers

PMID31731792
PMCPMC6893769
OpenAlexW2985285467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.